Dianthus Therapeutics Inc

DNTHNASDAQ · US

Holders

ACQUIREDT+7
Read Simon
Dianthus Therapeutics Inc · NASDAQ
+2,778 sh · $51.0K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Read Simon
Dianthus Therapeutics Inc · NASDAQ
−2,778 sh · $326.6K
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Polen Capital Management
Dianthus Therapeutics Inc · NASDAQ
9,333 sh · $909.8K
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Polen Capital Management
Dianthus Therapeutics Inc · NASDAQ
4,119 sh · $345.7K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Dianthus Therapeutics Inc · NASDAQ
1,603,547 sh · $41.5M
Filed 30 Jun 2024SEC 13Fview source